Evidence map›Paper›PMID 40236458›Full record

ArticleFrontiers in medicine2025

Enhancing multi-class neurodegenerative disease classification using deep learning and explainable local interpretable model-agnostic explanations.

Jamel Baili, Abdullah Alqahtani, Ahmad Almadhor, Abdullah Al Hejaili, Tai-Hoon Kim

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jamel BailiDepartment of Computer Engineering, College of Computer Science, King Khalid University, Abha, Saudi Arabia.
Abdullah AlqahtaniDepartment of Computer Science, College of Computer Engineering and Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Ahmad AlmadhorDepartment of Computer Engineering and Networks, College of Computer and Information Sciences, Jouf University, Sakaka, Saudi Arabia.
Abdullah Al HejailiFaculty of Computers and Information Technology, Computer Science Department, University of Tabuk, Tabuk, Saudi Arabia.
Tai-Hoon KimSchool of Electrical and Computer Engineering, Chonnam National University, Yeosu-si, Jeollanam-do, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Alzheimer's disease (AD) and Parkinson's disease (PD) are two of the most prevalent neurodegenerative disorders, necessitating accurate diagnostic approaches for early detection and effective management. Methods: This study introduces two deep learning architectures, the Residual-based Attention Convolutional Neural Network (RbACNN) and the Inverted Residual-based Attention Convolutional Neural Network (IRbACNN), designed to enhance medical image classification for AD and PD diagnosis. By integrating self-attention mechanisms, these models improve feature extraction, enhance interpretability, and address the limitations of traditional deep learning methods. Additionally, explainable AI (XAI) techniques are incorporated to provide model transparency and improve clinical trust in automated diagnoses. Preprocessing steps such as histogram equalization and batch creation are applied to optimize image quality and balance the dataset. Results: The proposed models achieved an outstanding classification accuracy of 99.92%. Discussion: The results demonstrate that these architectures, in combination with XAI, facilitate early and precise diagnosis, thereby contributing to reducing the global burden of neurodegenerative diseases.

Indexed as

Alzheimer's disease (AD)deep learning modelsmedical image analysisneurodegenerative disordersParkinson's disease (PD)

Identifiers

PMID40236458
PMCPMC11996893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.